Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
by jovita
Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
by jesse588
Mandatory criteria: . Probability based sampling. ...
% of Global HCV Seropositive Cases
% of Global HCV Seropositive Cases
by faith
Global epidemiology of hepatitis C virus infection...
HIV-HCV Coinfection in the era of effective antiviral therapy
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
HIV 2015-2016: New Agents, New Strategies
HIV 2015-2016: New Agents, New Strategies
by ellena-manuel
Learning Objectives. EARLY VS DEFERRED ART. The C...
Advances in the Treatment of
Advances in the Treatment of
by danika-pritchard
HCV Genotype 3 and HIV/HCV Coinfection . What's S...
Peginterferon alfa-2a +
Peginterferon alfa-2a +
by stefany-barnette
RBV . versus. Interferon alfa. -. 2a + RBV . ACT...
What’s New in Hepatitis C
What’s New in Hepatitis C
by debby-jeon
Diana L. . Sylvestre. , MD. University of CA, San...
Making the Impossible Possible
Making the Impossible Possible
by phoebe-click
Eradicate Hepatitis C Virus . A pilot of treatmen...
LDV/SOF 90/400 mg
LDV/SOF 90/400 mg
by aaron
qd. Non-randomised. Open-label. N =. 21. W12. SV...
Elbasvir
Elbasvir
by pamella-moone
+ . Grazoprevir. in . GT 1 . and Chronic Renal ...
SAPPHIRE-I
SAPPHIRE-I
by ellena-manuel
Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...
Simeprevir
Simeprevir
by alida-meadow
versus . Telaprevir. . with PR in GT1 . ATTAIN ...
PEG alfa-2a +
PEG alfa-2a +
by tawny-fly
RBV . versus. . PEG alfa-. 2a . versus. INF + R...
TURQUOISE-I
TURQUOISE-I
by marina-yarberry
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
TURQUOISE-II
TURQUOISE-II
by pasty-toler
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PW
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PW
by ellena-manuel
G. . Ntetskas. , V. . Papastergiou. , L. . Skorda...
TURQUOISE-I
TURQUOISE-I
by natalia-silvester
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
TURQUOISE-II
TURQUOISE-II
by giovanna-bartolotta
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
CURRY
CURRY
by faustina-dinatale
Design. Open-label. CURRY . Study. : SOF + RBV fo...
Jennifer Layden, MD, PhD
Jennifer Layden, MD, PhD
by olivia-moreira
Jennifer Layden, MD, PhD Assistant Professor of M...
PEG alfa-2a RBV versus
PEG alfa-2a RBV versus
by alexa-scheidler
. PEG alfa-. 2a . versus. INF RBV . APRICOT S...
FISSION Design Objective
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
LiveR x Study Eradicating Hepatitis C in Alberta
LiveR x Study Eradicating Hepatitis C in Alberta
by remy477
Cari Egan, RN, BN, MSc, PhD. LiveRx Team. Disclosu...
GP Study Afternoon: Viral Hepatitis
GP Study Afternoon: Viral Hepatitis
by madison
Cockburn Lecture Theatre, St Marys Hospital. Wedne...
dress for CorUluhan Sili MD Marmara University Faculty of Medicine D
dress for CorUluhan Sili MD Marmara University Faculty of Medicine D
by cecilia
39 nsan baklk yetmez...
European Journal of General Medicine94
European Journal of General Medicine94
by rose
Prevalence of Hepatitis C Virus The present study...
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
by christina
for Hepatitis C Virus Diagnosis: Usefulness among...
Viral hepatitis Best of ILC 2019
Viral hepatitis Best of ILC 2019
by stella
About these slides. These slides provide highlight...
Daclatasvir - Asunaprevir
Daclatasvir - Asunaprevir
by queenie
-. Beclabuvir in GT1 Patients without Cirrhosis. U...
Viral hepatitis Best of ILC 2018
Viral hepatitis Best of ILC 2018
by roberts
About these slides. These slides provide highlight...
SMV + DCV + SOF Open label
SMV + DCV + SOF Open label
by summer
≥ 18 years. Chronic HCV infection. Genotype 1 or...
C-EDGE Co-Infected: Phase 3 Study of
C-EDGE Co-Infected: Phase 3 Study of
by giovanna-bartolotta
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...
Update on Hepatitis C SSHA Conference 2015
Update on Hepatitis C SSHA Conference 2015
by Hiphopkid
Daniel Bradshaw. Locum Consultant . GUM/HIV. Brigh...
Single arm
Single arm
by min-jolicoeur
Open label. ≥ . 18 years, . HCV genotype 1 to ...
ION-4
ION-4
by briana-ranney
Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...
SMV 150 mg
SMV 150 mg
by faustina-dinatale
qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....
Dore G. J
Dore G. J
by myesha-ticknor
Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...
Peginterferon alfa-2a (
Peginterferon alfa-2a (
by tatyana-admore
Pegasys. ). Prepared by: David Spach, MD & H....